Bristol-Myers Squibb Co
Bristol-Myers Squibb's Climate Target Data Preview
As of 2024, Bristol-Myers Squibb has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Bristol-Myers Squibb ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  a | 2033 |
Absolute-based Target | Scope 3 - Fuel- and Energy-Related Services (Cat. 3) | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data. a | 2033 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Bristol-Myers Squibb’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bristol-Myers Squibb’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Bristol-Myers Squibb's Greenhouse Gas Emissions Pathways
As of 2024, Bristol-Myers Squibb has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint. a
Does Bristol-Myers Squibb have a target to reduce the emissions from its operations?
As of 2024, Bristol-Myers Squibb has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources. a
Bristol-Myers Squibb's most ambitious operational target is to reduce these emissions by 54.6% by 2033, compared to a baseline of 372,834 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022. a
As of 2024, Bristol-Myers Squibb is ahead of schedule on its operational emissions reduction target, having achieved 30.18% of the planned reduction. a
Bristol-Myers Squibb's Operational (Scope 1+2) Emissions Pathway
Does Bristol-Myers Squibb have a target to reduce the emissions from its value chain?
As of 2024, Bristol-Myers Squibb has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol. a
Bristol-Myers Squibb's most ambitious value chain target is to reduce these emissions by 54.6% by 2033, compared to a baseline of 71,900 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022. a
As of 2024, Bristol-Myers Squibb is ahead of schedule on its value chain emissions reduction target, having achieved 31.52% of the planned reduction. a